Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation

Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation

Jing Liu,* Ligang Xing,* Xue Meng, Jinbo Yue, Xiangjiao Meng, Peng Xie, Xiaolin Li, Li Kong, Jinming YuDepartment of Radiation Oncology, Shandong Province Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong University, Jinan, People’s Republic of China*Th...

Full description

Bibliographic Details
Main Authors: Liu J, Xing L, Meng X, Yue J, Xie P, Li X, Kong L, Yu J
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:OncoTargets and Therapy
Subjects:
pulmonary adenocarcinoma
brain metastasis
epidermal growth factor receptor
erlotinib
match-pair analysis
Online Access:https://www.dovepress.com/risk-of-brain-metastasis-reduced-after-erlotinib-treatment-in-advanced-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/risk-of-brain-metastasis-reduced-after-erlotinib-treatment-in-advanced-peer-reviewed-article-OTT

Similar Items